Exact Mass: 432.23341760000005
Exact Mass Matches: 432.23341760000005
Found 382 metabolites which its exact mass value is equals to given mass value 432.23341760000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Buclizine
C28H33ClN2 (432.23321280000005)
Buclizine is only found in individuals that have used or taken this drug. It is an antihistamine of the piperazine derivative family. [Wikipedia]Vomiting (emesis) is essentially a protective mechanism for removing irritant or otherwise harmful substances from the upper GI tract. Emesis or vomiting is controlled by the vomiting centre in the medulla region of the brain, an important part of which is the chemotrigger zone (CTZ). The vomiting centre possesses neurons which are rich in muscarinic cholinergic and histamine containing synapses. These types of neurons are especially involved in transmission from the vestibular apparatus to the vomiting centre. Motion sickness principally involves overstimulation of these pathways due to various sensory stimuli. Hence the action of buclizine which acts to block the histamine receptors in the vomiting centre and thus reduce activity along these pathways. Furthermore since buclizine possesses anti-cholinergic properties as well, the muscarinic receptors are similarly blocked. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
2-piperidin-3-yloxy-8-propan-2-yl-N-[(2-pyrazol-1-ylphenyl)methyl]pyrazolo[1,5-a][1,3,5]triazin-4-amine
Glucosyl (2E,6E,10x)-10,11-dihydroxy-2,6-farnesadienoate
Glucosyl (2E,6E,10x)-10,11-dihydroxy-2,6-farnesadienoate is found in alcoholic beverages. Glucosyl (2E,6E,10x)-10,11-dihydroxy-2,6-farnesadienoate is present in Riesling wine. Present in Riesling wine. Glucosyl (2E,6E,10x)-10,11-dihydroxy-2,6-farnesadienoate is found in alcoholic beverages.
1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate
1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate is also known as PA(18:3(6Z,9Z,12Z)/0:0). 1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate
1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate is also known as PA(18:3(9Z,12Z,15Z)/0:0). 1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(18:3(6Z,9Z,12Z)/0:0)
LysoPA(18:3(6Z,9Z,12Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(18:3(6Z,9Z,12Z)/0:0), in particular, consists of one chain of gamma-linolenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(18:3(9Z,12Z,15Z)/0:0)
LysoPA(18:3(9Z,12Z,15Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(18:3(9Z,12Z,15Z)/0:0), in particular, consists of one chain of alpha-linolenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
p-[(R)-3-[Bis-[(R)-beta-hydroxyphenethyl]amino]butyl]benzamide
(1S,4S,5S,7R,10R)-10,11,14-trihydroxyguai-3-one 11-O-beta-D-glucopyranoside|(1S,4S,5S,7R,10R)-10,11,14-Trihydroxyguai-3-one 11-O-??-D-glucopyranoside|(1S,4S,5S,7R,10R)-10,11,14-trihydroxyguaian-3-one 11-O-beta-D-glucopyranoside
1beta,6beta,9alpha,11-tetrahydroxy-trans-eudesm-3-ene-6-O-beta-D-glucopyranoside
2,4,6-tri-O-acetyl-3-O-isobutyryl-1-O-2-methylbutyryl-chiro-inositol
(14R,16R,19S,20R)-(1-hydroxy-16,20-dimethyl-20-(24-methylpent-23-en-21-yl)- 14,15,16,17,18,19-hexahydro-6H-3,16-epoxybenzo[c]chromen-6-yl)(phenyl)methanone|benzophenone-congestiflorone
(1beta,4alphaH,5alpha,10betaH)-2beta,7alpha,8alpha-trihydroxy-10,11-epoxy-guaiane 2-O-beta-D-glucopyranoside|daucuside
2alpha,7,12-trihydroxykessane 2-O-beta-D-glucopyranoside
Buclizine
C28H33ClN2 (432.23321280000005)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Ala Phe Pro Val
Ala Phe Val Pro
Ala Ile Met Val
C19H36N4O5S (432.24062860000004)
Ala Ile Val Met
C19H36N4O5S (432.24062860000004)
Ala Lys Asn Thr
Ala Lys Gln Ser
Ala Lys Ser Gln
Ala Lys Thr Asn
Ala Leu Met Val
C19H36N4O5S (432.24062860000004)
Ala Leu Val Met
C19H36N4O5S (432.24062860000004)
Ala Met Ile Val
C19H36N4O5S (432.24062860000004)
Ala Met Leu Val
C19H36N4O5S (432.24062860000004)
Ala Met Val Ile
C19H36N4O5S (432.24062860000004)
Ala Met Val Leu
C19H36N4O5S (432.24062860000004)
Ala Asn Lys Thr
Ala Asn Thr Lys
Ala Pro Phe Val
Ala Pro Val Phe
Ala Gln Lys Ser
Ala Gln Ser Lys
Ala Ser Lys Gln
Ala Ser Gln Lys
Ala Thr Lys Asn
Ala Thr Asn Lys
Ala Val Phe Pro
Ala Val Ile Met
C19H36N4O5S (432.24062860000004)
Ala Val Leu Met
C19H36N4O5S (432.24062860000004)
Ala Val Met Ile
C19H36N4O5S (432.24062860000004)
Ala Val Met Leu
C19H36N4O5S (432.24062860000004)
Ala Val Pro Phe
Cys Ile Val Val
C19H36N4O5S (432.24062860000004)
Cys Leu Val Val
C19H36N4O5S (432.24062860000004)
Cys Val Ile Val
C19H36N4O5S (432.24062860000004)
Cys Val Leu Val
C19H36N4O5S (432.24062860000004)
Cys Val Val Ile
C19H36N4O5S (432.24062860000004)
Cys Val Val Leu
C19H36N4O5S (432.24062860000004)
Phe Ala Pro Val
Phe Ala Val Pro
Phe Gly Ile Pro
Phe Gly Leu Pro
Phe Gly Pro Ile
Phe Gly Pro Leu
Phe Ile Gly Pro
Phe Ile Pro Gly
Phe Leu Gly Pro
Phe Leu Pro Gly
Phe Pro Ala Val
Phe Pro Gly Ile
Phe Pro Gly Leu
Phe Pro Ile Gly
Phe Pro Leu Gly
Phe Pro Val Ala
Phe Val Ala Pro
Phe Val Pro Ala
Gly Phe Ile Pro
Gly Phe Leu Pro
Gly Phe Pro Ile
Gly Phe Pro Leu
Gly Ile Phe Pro
Gly Ile Ile Met
C19H36N4O5S (432.24062860000004)
Gly Ile Leu Met
C19H36N4O5S (432.24062860000004)
Gly Ile Met Ile
C19H36N4O5S (432.24062860000004)
Gly Ile Met Leu
C19H36N4O5S (432.24062860000004)
Gly Ile Pro Phe
Gly Lys Gln Thr
Gly Lys Thr Gln
Gly Leu Phe Pro
Gly Leu Ile Met
C19H36N4O5S (432.24062860000004)
Gly Leu Leu Met
C19H36N4O5S (432.24062860000004)
Gly Leu Met Ile
C19H36N4O5S (432.24062860000004)
Gly Leu Met Leu
C19H36N4O5S (432.24062860000004)
Gly Leu Pro Phe
Gly Met Ile Ile
C19H36N4O5S (432.24062860000004)
Gly Met Ile Leu
C19H36N4O5S (432.24062860000004)
Gly Met Leu Ile
C19H36N4O5S (432.24062860000004)
Gly Met Leu Leu
C19H36N4O5S (432.24062860000004)
Gly Pro Phe Ile
Gly Pro Phe Leu
Gly Pro Ile Phe
Gly Pro Leu Phe
Gly Gln Lys Thr
Gly Gln Thr Lys
Gly Thr Lys Gln
Gly Thr Gln Lys
Ile Ala Met Val
C19H36N4O5S (432.24062860000004)
Ile Ala Val Met
C19H36N4O5S (432.24062860000004)
Ile Cys Val Val
C19H36N4O5S (432.24062860000004)
Ile Phe Gly Pro
Ile Phe Pro Gly
Ile Gly Phe Pro
Ile Gly Ile Met
C19H36N4O5S (432.24062860000004)
Ile Gly Leu Met
C19H36N4O5S (432.24062860000004)
Ile Gly Met Ile
C19H36N4O5S (432.24062860000004)
Ile Gly Met Leu
C19H36N4O5S (432.24062860000004)
Ile Gly Pro Phe
Ile Ile Gly Met
C19H36N4O5S (432.24062860000004)
Ile Ile Met Gly
C19H36N4O5S (432.24062860000004)
Ile Leu Gly Met
C19H36N4O5S (432.24062860000004)
Ile Leu Met Gly
C19H36N4O5S (432.24062860000004)
Ile Met Ala Val
C19H36N4O5S (432.24062860000004)
Ile Met Gly Ile
C19H36N4O5S (432.24062860000004)
Ile Met Gly Leu
C19H36N4O5S (432.24062860000004)
Ile Met Ile Gly
C19H36N4O5S (432.24062860000004)
Ile Met Leu Gly
C19H36N4O5S (432.24062860000004)
Ile Met Val Ala
C19H36N4O5S (432.24062860000004)
Ile Pro Phe Gly
Ile Pro Gly Phe
Ile Val Ala Met
C19H36N4O5S (432.24062860000004)
Ile Val Cys Val
C19H36N4O5S (432.24062860000004)
Ile Val Met Ala
C19H36N4O5S (432.24062860000004)
Ile Val Val Cys
C19H36N4O5S (432.24062860000004)
Lys Ala Asn Thr
Lys Ala Gln Ser
Lys Ala Ser Gln
Lys Ala Thr Asn
Lys Gly Gln Thr
Lys Gly Thr Gln
Lys Asn Ala Thr
Lys Asn Thr Ala
Lys Gln Ala Ser
Lys Gln Gly Thr
Lys Gln Ser Ala
Lys Gln Thr Gly
Lys Ser Ala Gln
Lys Ser Gln Ala
Lys Thr Ala Asn
Lys Thr Gly Gln
Lys Thr Asn Ala
Lys Thr Gln Gly
Leu Ala Met Val
C19H36N4O5S (432.24062860000004)
Leu Ala Val Met
C19H36N4O5S (432.24062860000004)
Leu Cys Val Val
C19H36N4O5S (432.24062860000004)
Leu Phe Gly Pro
Leu Phe Pro Gly
Leu Gly Phe Pro
Leu Gly Ile Met
C19H36N4O5S (432.24062860000004)
Leu Gly Leu Met
C19H36N4O5S (432.24062860000004)
Leu Gly Met Ile
C19H36N4O5S (432.24062860000004)
Leu Gly Met Leu
C19H36N4O5S (432.24062860000004)
Leu Gly Pro Phe
Leu Ile Gly Met
C19H36N4O5S (432.24062860000004)
Leu Ile Met Gly
C19H36N4O5S (432.24062860000004)
Leu Leu Gly Met
C19H36N4O5S (432.24062860000004)
Leu Leu Met Gly
C19H36N4O5S (432.24062860000004)
Leu Met Ala Val
C19H36N4O5S (432.24062860000004)
Leu Met Gly Ile
C19H36N4O5S (432.24062860000004)
Leu Met Gly Leu
C19H36N4O5S (432.24062860000004)
Leu Met Ile Gly
C19H36N4O5S (432.24062860000004)
Leu Met Leu Gly
C19H36N4O5S (432.24062860000004)
Leu Met Val Ala
C19H36N4O5S (432.24062860000004)
Leu Pro Phe Gly
Leu Pro Gly Phe
Leu Val Ala Met
C19H36N4O5S (432.24062860000004)
Leu Val Cys Val
C19H36N4O5S (432.24062860000004)
Leu Val Met Ala
C19H36N4O5S (432.24062860000004)
Leu Val Val Cys
C19H36N4O5S (432.24062860000004)
Met Ala Ile Val
C19H36N4O5S (432.24062860000004)
Met Ala Leu Val
C19H36N4O5S (432.24062860000004)
Met Ala Val Ile
C19H36N4O5S (432.24062860000004)
Met Ala Val Leu
C19H36N4O5S (432.24062860000004)
Met Gly Ile Ile
C19H36N4O5S (432.24062860000004)
Met Gly Ile Leu
C19H36N4O5S (432.24062860000004)
Met Gly Leu Ile
C19H36N4O5S (432.24062860000004)
Met Gly Leu Leu
C19H36N4O5S (432.24062860000004)
Met Ile Ala Val
C19H36N4O5S (432.24062860000004)
Met Ile Gly Ile
C19H36N4O5S (432.24062860000004)
Met Ile Gly Leu
C19H36N4O5S (432.24062860000004)
Met Ile Ile Gly
C19H36N4O5S (432.24062860000004)
Met Ile Leu Gly
C19H36N4O5S (432.24062860000004)
Met Ile Val Ala
C19H36N4O5S (432.24062860000004)
Met Leu Ala Val
C19H36N4O5S (432.24062860000004)
Met Leu Gly Ile
C19H36N4O5S (432.24062860000004)
Met Leu Gly Leu
C19H36N4O5S (432.24062860000004)
Met Leu Ile Gly
C19H36N4O5S (432.24062860000004)
Met Leu Leu Gly
C19H36N4O5S (432.24062860000004)
Met Leu Val Ala
C19H36N4O5S (432.24062860000004)
Met Val Ala Ile
C19H36N4O5S (432.24062860000004)
Met Val Ala Leu
C19H36N4O5S (432.24062860000004)
Met Val Ile Ala
C19H36N4O5S (432.24062860000004)
Met Val Leu Ala
C19H36N4O5S (432.24062860000004)
Asn Ala Lys Thr
Asn Ala Thr Lys
Asn Lys Ala Thr
Asn Lys Thr Ala
Asn Thr Ala Lys
Asn Thr Lys Ala
Pro Ala Phe Val
Pro Ala Val Phe
Pro Phe Ala Val
Pro Phe Gly Ile
Pro Phe Gly Leu
Pro Phe Ile Gly
Pro Phe Leu Gly
Pro Phe Val Ala
Pro Gly Phe Ile
Pro Gly Phe Leu
Pro Gly Ile Phe
Pro Gly Leu Phe
Pro Ile Phe Gly
Pro Ile Gly Phe
Pro Leu Phe Gly
Pro Leu Gly Phe
Pro Val Ala Phe
Pro Val Phe Ala
Gln Ala Lys Ser
Gln Ala Ser Lys
Gln Gly Lys Thr
Gln Gly Thr Lys
Gln Lys Ala Ser
Gln Lys Gly Thr
Gln Lys Ser Ala
Gln Lys Thr Gly
Gln Ser Ala Lys
Gln Ser Lys Ala
Gln Thr Gly Lys
Gln Thr Lys Gly
Ser Ala Lys Gln
Ser Ala Gln Lys
Ser Lys Ala Gln
Ser Lys Gln Ala
Ser Gln Ala Lys
Ser Gln Lys Ala
Thr Ala Lys Asn
Thr Ala Asn Lys
Thr Gly Lys Gln
Thr Gly Gln Lys
Thr Lys Ala Asn
Thr Lys Gly Gln
Thr Lys Asn Ala
Thr Lys Gln Gly
Thr Asn Ala Lys
Thr Asn Lys Ala
Thr Gln Gly Lys
Thr Gln Lys Gly
Val Ala Phe Pro
Val Ala Ile Met
C19H36N4O5S (432.24062860000004)
Val Ala Leu Met
C19H36N4O5S (432.24062860000004)
Val Ala Met Ile
C19H36N4O5S (432.24062860000004)
Val Ala Met Leu
C19H36N4O5S (432.24062860000004)
Val Ala Pro Phe
Val Cys Ile Val
C19H36N4O5S (432.24062860000004)
Val Cys Leu Val
C19H36N4O5S (432.24062860000004)
Val Cys Val Ile
C19H36N4O5S (432.24062860000004)
Val Cys Val Leu
C19H36N4O5S (432.24062860000004)
Val Phe Ala Pro
Val Phe Pro Ala
Val Ile Ala Met
C19H36N4O5S (432.24062860000004)
Val Ile Cys Val
C19H36N4O5S (432.24062860000004)
Val Ile Met Ala
C19H36N4O5S (432.24062860000004)
Val Ile Val Cys
C19H36N4O5S (432.24062860000004)
Val Leu Ala Met
C19H36N4O5S (432.24062860000004)
Val Leu Cys Val
C19H36N4O5S (432.24062860000004)
Val Leu Met Ala
C19H36N4O5S (432.24062860000004)
Val Leu Val Cys
C19H36N4O5S (432.24062860000004)
Val Met Ala Ile
C19H36N4O5S (432.24062860000004)
Val Met Ala Leu
C19H36N4O5S (432.24062860000004)
Val Met Ile Ala
C19H36N4O5S (432.24062860000004)
Val Met Leu Ala
C19H36N4O5S (432.24062860000004)
Val Pro Ala Phe
Val Pro Phe Ala
Val Val Cys Ile
C19H36N4O5S (432.24062860000004)
Val Val Cys Leu
C19H36N4O5S (432.24062860000004)
Val Val Ile Cys
C19H36N4O5S (432.24062860000004)
Val Val Leu Cys
C19H36N4O5S (432.24062860000004)
Glucosyl (2E,6E,10x)-10,11-dihydroxy-2,6-farnesadienoate
1-N-Boc-4-(3-Cbz-amino-3-methoxycarbonylallyl)piperidine
Bms-911543
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor
(R)-4-((4-(((4-(Tetrahydrofuran-3-yloxy)-1,2-benzisoxazol-3-yl)oxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol
PF-04995274 is a potent, high-affinity, orally active and partial serotonin 4 receptor (5-HT4R) agonist. PF-04995274 has an EC50 range of 0.26-0.47 nM for human 5-HT4A/4B/4D/4E (Ki range of 0.15-0.46 nM), and has an EC50 range of 0.59-0.65 nM for rat 5-HT4S/4L/4E (Ki of 0.30 nM for rat 5-HT4S). PF-04995274 is brain penetrant and can be used for cognitive disorders associated with Alzheimer's disease[1][2][3].
Platensimide A
A polycyclic cage compound that is a carboxamide obtained by the formal condensation of the amino group of 4-(acetylamino)-2-aminobutanoic acid with the carboxy group of the oxatetracyclic cage component. It is isolated from Streptomyces platensis.
1,1-(1,3-Phenylenebis(propane-2,2-diyl))bis(3-(pyridin-3-yl)urea)
(3R,4S,6R)-N-[(2-methoxyphenyl)methyl]-6-[(4-pyridin-2-yltriazol-1-yl)methyl]-1-azabicyclo[2.2.2]octane-3-carboxamide
2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
[(8S,9S,10R)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C26H29FN4O (432.23252759999997)
[(8R,9R,10S)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C26H29FN4O (432.23252759999997)
[(8S,9S,10S)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C26H29FN4O (432.23252759999997)
2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
[(8S,9R,10R)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C26H29FN4O (432.23252759999997)
[(8R,9R,10R)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C26H29FN4O (432.23252759999997)
[(8S,9R,10S)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C26H29FN4O (432.23252759999997)
[(8R,9S,10R)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C26H29FN4O (432.23252759999997)
[(8R,9S,10S)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C26H29FN4O (432.23252759999997)
1-Linoleoylglycerone 3-phosphate
A 1-acylglycerone 3-phosphate in which the acyl group is specified as linoleoyl.
2-Hydroxy-3-(phosphonooxy)propyl (9Z,12Z,15Z)-9,12,15-octadecatrienoate
1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate
1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate
1-Oleoylglycerone 3-phosphate(2-)
A 1-acylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleoylglycerone 3-phosphate; major species at pH 7.3.
1-(gamma-linolenoyl)-sn-glycero-3-phosphate
A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as gamma-linolenoyl (6Z,9Z,12Z-octadecatrienoyl).
1-linolenoyl-sn-glycero-3-phosphate
A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as linolenoyl (9Z,12Z,15Z-octadecatrienoyl).
1-Linoleoyl-sn-glycero-3-phosphate(2-)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-linoleoyl-sn-glycero-3-phosphate.
(2s,3r,4s,5s,6r)-2-{[(1r,2r,4s)-2,4-dihydroxy-2-[(1e,3e)-5-hydroxy-3-methylpenta-1,3-dien-1-yl]-1,3,3-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-{[5-hydroxy-4a-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-8-methyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(1s,2r,4as,5s,8ar)-5-hydroxy-4a-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-8-methylidene-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
3-ethylidene-2-{9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine
(3r,4ar,5s,6s,8ar)-6-hydroxy-3-(2-hydroxypropan-2-yl)-5,8a-dimethyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydro-1h-naphthalen-2-one
2-{[5-hydroxy-4a-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-8-methylidene-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(1r,2r,3r,5r,6r,8s,12s)-8,12-dihydroxy-1,5,9,9-tetramethyl-10-oxatricyclo[6.2.2.0²,⁶]dodecan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(1r,2r,4s)-2,4-dihydroxy-2-(5-hydroxy-3-methylpenta-1,3-dien-1-yl)-1,3,3-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
3β-angeloyloxy-10β-hydroxy-6β-methoxy-eremophila-7(11),8(9)-dien-8,12-olide
C26H37ClO3 (432.24310820000005)
{"Ingredient_id": "HBIN008180","Ingredient_name": "3\u03b2-angeloyloxy-10\u03b2-hydroxy-6\u03b2-methoxy-eremophila-7(11),8(9)-dien-8,12-olide","Alias": "NA","Ingredient_formula": "C26H37ClO3","Ingredient_Smile": "COC(=O)CCCC=CCC1C(CCC1Cl)C2=CC=C(C=C2)C(C3CCCCC3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1227","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-eudesmene-1,6,11,14-tetrol; (1α,5β,6β,10α)-form,6-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN008540","Ingredient_name": "3-eudesmene-1,6,11,14-tetrol; (1\u03b1,5\u03b2,6\u03b2,10\u03b1)-form,6-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H36O9","Ingredient_Smile": "NA","Ingredient_weight": "432.51","OB_score": "NA","CAS_id": "202278-90-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8132","PubChem_id": "NA","DrugBank_id": "NA"}
4,14-epoxy-1,6,11-eudesmanetriol; (1α,4α,5β,6β,10α)-form,6-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN009819","Ingredient_name": "4,14-epoxy-1,6,11-eudesmanetriol; (1\u03b1,4\u03b1,5\u03b2,6\u03b2,10\u03b1)-form,6-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H36O9","Ingredient_Smile": "NA","Ingredient_weight": "432.51","OB_score": "NA","CAS_id": "202278-88-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7937","PubChem_id": "NA","DrugBank_id": "NA"}
4(15)-eudesmene-1,6,11,14-tetrol; (1α,5β,6β,10α)-form,6-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN009831","Ingredient_name": "4(15)-eudesmene-1,6,11,14-tetrol; (1\u03b1,5\u03b2,6\u03b2,10\u03b1)-form,6-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H36O9","Ingredient_Smile": "NA","Ingredient_weight": "432.51","OB_score": "NA","CAS_id": "202278-89-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7975","PubChem_id": "NA","DrugBank_id": "NA"}